Ati cautat: studii clinice
Protocol terapeutic: L01XE21 – DCI REGORAFENIBUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L01XC32 – DCI ATEZOLIZUMAB (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L01XC16 – DCI DINUTUXIMAB BETA (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: A16AB17 – DCI CERLIPONASUM ALFA (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: A16AB12 – DCI ELOSULFASE ALFA (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L04AC11 – DCI SILTUXIMABUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L01XE39 – DCI MIDOSTAURINUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L01XE28 – DCI CERITINIBUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L01XE12 – DCI VANDETANIBUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L01XC31 – DCI AVELUMABUM (actualizat APRILIE 2022 conform ordin MS/CNAS NR 1206/233/2022)
